CATTANEO, DARIO
CATTANEO, DARIO
Universita' degli Studi di MILANO
Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic
2024 D. Cattaneo, A. Torre, M. Schiuma, A. Civati, G. Casalini, A. Gori, S. Antinori, C. Gervasoni
Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals
2024 A. Giacomelli, C.L. Ciubotariu, M. Zacheo, A. Rabbione, M. Pieruzzi, F. Barone, A. Poloni, G. Casalini, G. Pozza, M. Colaneri, M. Passerini, A. Lisa Ridolfo, C. Gervasoni, D. Cattaneo, A. Gori, S. Antinori
Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges
2024 M. Colaneri, C. Genovese, P. Valsecchi, M. Calia, D. Cattaneo, A. Gori, R. Bruno, E. Seminari
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections
2024 D. Cattaneo, M. Fusi, L. Galli, C. Genovese, R. Giorgi, M. Matone, S. Merli, M. Colaneri, A. Gori
Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic
2023 D. Cattaneo, L. Oreni, P. Meraviglia, D. Minisci, N. Astuti, S. Antinori, A. Gori, C. Gervasoni
Management of diabetes mellitus in people living with HIV: A single-center experience
2023 D. Cattaneo, A. Gidaro, A. Rossi, A. Merlo, T. Formenti, P. Meraviglia, S. Antinori, C. Gervasoni
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
2023 D. Cattaneo, A. Torre, M. Schiuma, A. Civati, S. Lazzarin, G. Rizzardini, A. Gori, S. Antinori, C. Gervasoni
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
2023 D. Cattaneo, M. Fusi, M. Colaneri, C. Fusetti, C. Genovese, R. Giorgi, M. Matone, S. Merli, F. Petri, A. Gori
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects
2022 C. Carnovale, C. Perrotta, S. Baldelli, D. Cattaneo, C. Montrasio, S. S Barbieri, G. Pompilio, C. Vantaggiato, E.G.I. Clementi, M. Pozzi
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples
2021 S. Baldelli, M. Cerea, D. Mangioni, L. Alagna, A. Muscatello, A. Bandera, D. Cattaneo
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5
2021 S. Cheli, M. Fusi, A. De Silvestri, I. Bonini, E. Clementi, D. Cattaneo, C. Montrasio, S. Baldelli
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out
2021 M. Tagliabue, A.L. Ridolfo, P. Pina, G. Rizzolo, S. Belbusti, S. Antinori, M. Beltrami, D. Cattaneo, C. Gervasoni
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
2021 D. Cattaneo, L. Pasina, F. Conti, A. Giacomelli, L. Oreni, L. Pezzati, C. Bonazzetti, M. Piscaglia, G. Carrozzo, S. Antinori, C. Gervasoni
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens
2021 D. Cattaneo, M. Fusi, V. Micheli, C. Resnati, P. Meraviglia, M.V. Cossu, S. Vimercati, G.C. Bisinella, S. Baldelli, S. Antinori, C. Gervasoni
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment
2021 S. Cheli, S. Baldelli, A. De Silvestri, M. Fusi, D. Minisci, C. Gervasoni, D. Cattaneo, E. Clementi, P. Meraviglia, C. Montrasio
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate?
2021 A. Giacomelli, A. Lisa Ridolfo, L. Oreni, S. Vimercati, M. Albrecht, D. Cattaneo, S.G. Rimoldi, G. Rizzardini, M. Galli, S. Antinori
Pharmacokinetics of oral anticoagulants in patients with atrial fibrillation and extreme obesity
2021 V. Russo, D. Cattaneo, L. Giannetti, R. Bottino, N. Laezza, U. Atripaldi, E. Clementi
Does lopinavir really inhibit SARS-CoV-2?
2020 D. Cattaneo, C. Gervasoni, M. Corbellino, M. Galli, A. Riva, E. Clementi
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement
2020 M. Fabbiani, D. Cattaneo, A. Lombardi, M. Colaneri, M. Sambo, S. Novati, M. Fusi, R. Bruno
Clinical features and outcomes of HIV patients with coronavirus disease 2019
2020 C. Gervasoni, P. Meraviglia, A. Riva, A. Giacomelli, L. Oreni, D. Minisci, C. Atzori, A. Ridolfo, D. Cattaneo